Spots Global Cancer Trial Database for symptomatic uterine fibroids
Every month we try and update this database with for symptomatic uterine fibroids cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety of Treatment of Uterine Fibroids With Asoprisnil | NCT00156208 | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroid... | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
| Post Market TRUST - U.S.A. Study | NCT02163525 | Symptomatic Ute... | Global Fibroid ... Abdominal or La... Uterine Artery ... | 18 Years - | Acessa Health, Inc. | |
| Safety of Treatment of Uterine Fibroids With Asoprisnil | NCT00156208 | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroid... | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
| A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids | NCT00152256 | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroid... | Asoprisnil Asoprisnil Placebo | 18 Years - 53 Years | Abbott | |
| ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids | NCT01285960 | Uterine Fibroid... | ExAblate Treatm... | 18 Years - 64 Years | InSightec | |
| Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids | NCT00156195 | Leiomyoma Menorrhagia Metrorrhagia | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
| Safety & Efficacy of Non-Invasive Procedures Using Ultrasound-Guided HIFU 'Sonotrip V20' in Symptomatic Uterine Fibroids | NCT05972642 | Myoma;Uterus | HIFU-treatment | 19 Years - | Seoul National University Hospital | |
| Post Market TRUST - U.S.A. Study | NCT02163525 | Symptomatic Ute... | Global Fibroid ... Abdominal or La... Uterine Artery ... | 18 Years - | Acessa Health, Inc. | |
| Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids | NCT01328067 | Uterine Fibroid... Bleeding Pelvic Pain | Exablate 2100 Myomectomy | 18 Years - 50 Years | InSightec | |
| Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids | NCT01328067 | Uterine Fibroid... Bleeding Pelvic Pain | Exablate 2100 Myomectomy | 18 Years - 50 Years | InSightec | |
| Safety Study of ExAblate for the Treatment of Uterine Fibroids | NCT01142791 | Uterine Fibroid... | ExAblate | 18 Years - | InSightec | |
| Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids | NCT01328067 | Uterine Fibroid... Bleeding Pelvic Pain | Exablate 2100 Myomectomy | 18 Years - 50 Years | InSightec | |
| Spherical Gelfoam Versus Tri-acryl Microsphere for Uterine Artery Embolization for Symptomatic Fibroids | NCT04960293 | Symptomatic Ute... | uterine artery ... uterine artery ... | 20 Years - 60 Years | Yonsei University | |
| Post Market TRUST - U.S.A. Study | NCT02163525 | Symptomatic Ute... | Global Fibroid ... Abdominal or La... Uterine Artery ... | 18 Years - | Acessa Health, Inc. | |
| Spherical Gelfoam Versus Tri-acryl Microsphere for Uterine Artery Embolization for Symptomatic Fibroids | NCT04960293 | Symptomatic Ute... | uterine artery ... uterine artery ... | 20 Years - 60 Years | Yonsei University | |
| Magnetic Resonance Elastography (MRE) of Uterine Fibroids | NCT01229826 | Uterine Fibroid... | MR Elastography | 18 Years - 65 Years | Mayo Clinic | |
| Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions | NCT01750008 | Uterine Fibroid... Myomas | Global Fibroid ... Myomectomy | 18 Years - 55 Years | Acessa Health, Inc. | |
| Study of Asoprisnil in the Treatment of Uterine Fibroids. | NCT00156156 | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroid... | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
| Laparoscopic Cryoablation of Uterine Fibroids | NCT01735812 | Symptomatic Ute... | IceSense3 syste... | 30 Years - 50 Years | IceCure Medical Ltd. | |
| Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids | NCT00156195 | Leiomyoma Menorrhagia Metrorrhagia | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
| A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids | NCT00160381 | Leiomyoma Menorrhagia Metrorrhagia | Asoprisnil Asoprisnil Placebo | 18 Years - | Abbott |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
